Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Time to Thrombocytic Inhibition After Supine and Upright Ingestion of Efient

NCT01365741 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.

NCT NCT01365741
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01365741 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Time to Thrombocytic Inhibition After Supine and Upright Ingestion of Efient
Lead sponsor
Rigshospitalet, Denmark
Phase
Not applicable
Overall status
Completed
Start date
February 28, 2011
Completion date
April 30, 2016
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart disease, ischemic heart disease, st-elevation myocardial infarction